☆ 4.7 Article

Orforglipron (LY3502970), a novel, oral non-peptide glucagon-like peptide-1 receptor agonist: A Phase 1a, blinded, placebo-controlled, randomized, single- and multiple-ascending-dose study in healthy participants

DIABETES OBESITY & METABOLISM (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Chemistry, Medicinal

A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide-1 Receptor

David A. Griffith et al.

Summary: Peptide agonists of the glucagon-like peptide-1 receptor (GLP-1R) have been a breakthrough in diabetes therapy, but their use is limited due to the need for injection. In this study, a small-molecule GLP-1R agonist, danuglipron, was discovered that can be taken orally. Danuglipron showed the ability to promote GLP-1R signaling and increase insulin levels in primates, but not in rodents. This discovery opens up the possibility of oral small-molecule therapies targeting the validated GLP-1R for metabolic health.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

添加到收藏夹

Article Endocrinology & Metabolism

Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial

Nobuya Inagaki et al.

Summary: Tirzepatide showed superior efficacy in glycemic control and reduction in body weight compared to dulaglutide, suggesting a potential therapeutic use in Japanese patients with type 2 diabetes.

LANCET DIABETES & ENDOCRINOLOGY (2022)

添加到收藏夹

Article

Standards of Medical Care in Diabetes—2022 Abridged for Primary Care Providers

Clinical Diabetes (2021)

添加到收藏夹

Review Endocrinology & Metabolism

The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: A pathophysiological update

Michael A. Nauck et al.

Summary: Incretin hormones GIP and GLP-1 play a significant role in insulin secretion and glucose tolerance in the gut-endocrine pancreas axis. They also have additional effects on bone remodelling, lipid storage, gastric emptying, and may provide benefits for cardiovascular complications and neurodegenerative disorders. Recent research on GIP/GLP-1 receptor co-agonists has renewed interest in the potential therapeutic applications of incretin hormones.

DIABETES OBESITY & METABOLISM (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

Emerging glucagon-like peptide 1 receptor agonists for the treatment of obesity

Mathies M. Jepsen et al.

Summary: Obesity is a serious public health threat, with over 1.1 billion individuals projected to have obesity in 2030 if current trends continue. There is a strong interest in developing obesity treatments based on GLP-1 agonism, with many novel compounds in clinical development aiming to target the GLP-1 receptor or other hormonal systems involved in energy balance and metabolism. Semaglutide is the most advanced compound in clinical development and may become a benchmark for novel anti-obesity compounds utilizing GLP-1 receptor agonism.

EXPERT OPINION ON EMERGING DRUGS (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Danuglipron (PF-06882961) in type 2 diabetes: a randomized, placebo-controlled, multiple ascending-dose phase 1 trial

Aditi R. Saxena et al.

Summary: In this study, danuglipron showed good tolerability in T2D patients, with a safety profile consistent with the mechanism of action of GLP-1R agonism.

NATURE MEDICINE (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

Patient initiation and maintenance of GLP-1 RAs for treatment of obesity

Dhiren Patel et al.

Summary: This article focuses on the use of liraglutide 3.0 mg for weight management, providing data to assist healthcare providers in patient discussions. Additionally, promising areas of future research include dual receptor agonists and combining GLP-1 RA therapy with other molecules.

EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

Systemic delivery of peptides by the oral route: Formulation and medicinal chemistry approaches

D. J. Brayden et al.

ADVANCED DRUG DELIVERY REVIEWS (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist

Takahiro Kawai et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Nanoparticles: Oral Delivery for Protein and Peptide Drugs

Shu-jun Cao et al.

AAPS PHARMSCITECH (2019)

添加到收藏夹

Review Endocrinology & Metabolism

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

Soren L. Kristensen et al.

LANCET DIABETES & ENDOCRINOLOGY (2019)

添加到收藏夹

Article Pharmacology & Pharmacy

Safety and Pharmacokinetics of Single and Multiple Ascending Doses of the Novel Oral Human GLP-1 Analogue, Oral Semaglutide, in Healthy Subjects and Subjects with Type 2 Diabetes

Charlotte Granhall et al.

CLINICAL PHARMACOKINETICS (2019)

添加到收藏夹

Review Endocrinology & Metabolism

A Review of Practical Issues on the Use of Glucagon-Like Peptide-1 Receptor Agonists for the Management of Type 2 Diabetes

Irene Romera et al.

DIABETES THERAPY (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Targeting GLP-1 receptor trafficking to improve agonist efficacy

Ben Jones et al.

NATURE COMMUNICATIONS (2018)

添加到收藏夹

Review Endocrinology & Metabolism

Impact of GLP-1 receptor agonists on blood pressure, heart rate and hypertension among patients with type 2 diabetes: A systematic review and network meta-analysis

Feng Sun et al.

DIABETES RESEARCH AND CLINICAL PRACTICE (2015)

添加到收藏夹

Article Endocrinology & Metabolism

A 5-week study of the pharmacokinetics and pharmacodynamics of LY2189265, a novel, long-acting glucagon-like peptide-1 analogue, in patients with type 2 diabetes

P. Barrington et al.

DIABETES OBESITY & METABOLISM (2011)

添加到收藏夹

Review Pharmacology & Pharmacy

G protein-coupled receptor sorting to endosomes and lysosomes

Adriano Marchese et al.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.